Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    19366446 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors
Conditions: Cancer;   Brain Tumor
Interventions: Device: Low levels of amplitude-modulated electromagnetic fields;   Device: Emitter of low levels of amplitude-modulated electromagnetic fields
2 No longer available Low Levels of Electromagnetic Fields to Treat Advanced Cancer
Condition: Cancer
Intervention: Device: Intrabuccally-administered amplitude-modulated RFEM

Study has passed its completion date and status has not been verified in more than two years.